Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa

An effective vaccine against Pseudomonas aeruginosa would benefit people susceptible to severe infection. Vaccination targeting V antigen (PcrV) of the P. aeruginosa type III secretion system is a potential prophylactic strategy for reducing P. aeruginosa-induced acute lung injury and acute mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Keita, Kinoshita, Mao, Muranishi, Kentaro, Ohara, Junya, Sudo, Kazuki, Kawaguchi, Ken, Shimizu, Masaru, Naito, Yoshifumi, Moriyama, Kiyoshi, Sawa, Teiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304393/
https://www.ncbi.nlm.nih.gov/pubmed/37376477
http://dx.doi.org/10.3390/vaccines11061088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304393/
https://www.ncbi.nlm.nih.gov/pubmed/37376477
http://dx.doi.org/10.3390/vaccines11061088

Ejemplares similares